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Summary
Age-related defects in fibroblast differentiation and functionality
were previously shown to be associated with impaired hyaluro-
nan (HA) synthase 2 (HAS2) and epidermal growth factor receptor
(EGFR) function, as a result of upregulated microRNA-7 (miR-7)
expression. In aging fibroblasts, inhibiting miR-7 prevented the
dysregulation of the HA-mediated CD44/EGFR signaling pathway.
Here, we investigated transcriptional upregulation of miR-7 and
implicated the age-associated over-activation of JAK/STAT1 as a
primary candidate. STAT1 binding sites were identified on the
putative miR-7 promoter and stimulation of fibroblasts with the
inflammatory cytokine, interferon-c (IFN-c), significantly
increased miR-7 transcriptional activity and resulted in upregu-
lated miR-7 and loss of EGFR. Additionally, we demonstrated a
role for the anti-inflammatory steroid, 17b-estradiol (E2), in the
attenuation of miR-7 expression. E2 stimulation promoted estro-
gen receptor (ER) interactions with the miR-7 putative promoter
and suppressed miR-7 expression. E2 also attenuated STAT1
expression and activity. Furthermore, treatments with E2
restored fibroblast functionality, including proliferation, migra-
tion and differentiation, key events in effective wound healing.
In light of our findings, we propose that the regulation of miR-7
by pro- and anti-inflammatory mediators plays a wider role than
previously thought. The modulation of fibroblast functions and
ultimately wound healing by miR-7 activators or inhibitors could
provide realistic targets for the restoration of chronic wound
healing capabilities in the elderly.
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Introduction
Fibroblasts are central to remodeling and restoration of tissue integrity
during wound healing. Differentiation [triggered by transforming growth
factor (TGF)-b1], into a-smooth muscle actin (aSMA)-positive, contractile
myofibroblasts (Gabbiani, 2003), allows for wound closure and the
formation of collagen-rich scars. Fibroblasts isolated from aging skin,
however, show premature senescence, impaired migration, proliferation
and matrix generation (Campisi, 1998; Stephens et al., 2003). Our
recent studies showed aging fibroblasts were resistant to TGF-b1
differentiation (Midgley et al., 2013) and this may be an important
defect of wound healing in the elderly. In young fibroblasts, TGF-b1
activates two distinct, co-operating pathways. The first is the TGF-bR/
Smad2-mediated signaling pathway. The second is mediated by
hyaluronic acid (HA) and its receptor CD44. HA-mediated CD44
translocation within the plasma membrane allows for co-localization
with epidermal growth factor receptor (EGFR) in lipid rafts. This directs
intracellular signaling through extracellular signal-regulated kinases
(ERK1/2). In aged cells, the EGFR pathway is dysregulated due to
reduced expression and impaired CD44/EGFR co-localization, while the
Smad2 pathway remains intact. We have shown more recently that in
aged fibroblasts, reduced EGFR expression resulted from increased
expression of microRNA (miR)-7 (Midgley et al., 2014). Reducing miR-7
expression restored EGFR and the TGF-b1 differentiation response. In
contrast, overexpression of miR-7 in young fibroblasts decreased EGFR
expression and the TGF-b1 response. This novel mechanism of a miR-7-
dependent and age-associated functional effect on differentiation
highlights miR-7 as a potential target for restoring fibroblast functionality
and, by implication, chronic wound healing in the elderly.
Upregulation of miR-7 was reported to involve c-Myc binding the
miR-7 promoter and enhancing transcriptional activity. This was depen-
dent on the activation of EGFR-regulated ERK/c-Myc (Chou et al., 2010).
In addition, miR-7 has been reported to target Akt and blockade of the
EGFR-mediated PI3K/Akt pathway resulted in attenuated miR-7 expres-
sion (Fang et al., 2012). These studies highlight two self-regulatory loops
for miR-7 expression. In aging fibroblasts, the expression of EGFR is lost,
suggesting pathways involving EGFR-dependent c-Myc or Akt would not
be active. Therefore, upregulated expression of miR-7 in aged fibroblasts
is likely to be through an alternative, constitutively active pathway.
Interestingly, the inflammatory mediators, interferon-c (IFN-c) and
interleukin-6 (IL6), which primarily signal through the STAT1 and STAT3
pathways, respectively, were found to have increased expression in aged
mice (Busse et al., 2007). Furthermore, studies have correlated aging
with increased expression of inflammatory mediators, specifically
following menopause or andropause (Ershler & Keller, 2000; Tchkonia
et al., 2010). The findings that inflammatory regulators are present at
elevated levels in aged individuals could provide a pivotal role for the
immune system in the progression or cessation of successful wound
healing. Tumor necrosis factor-a (TNF-a) is a pro-inflammatory cytokine
involved in leukocyte recruitment, M1/M2 macrophage shifts and
delaying wound healing responses. Blockade of TNF-a increased matrix
synthesis and accelerated healing in murine models of age-related
impaired healing and excessive inflammation (Ashcroft et al., 2012). IL6
can display pro- and anti-inflammatory actions: IL6-KO mice exhibit
impaired granulation tissue formation and delayed cutaneous wound
healing; IL6-KO dermal fibroblasts had decreased production of matrix
enzymes, suggesting an IL6 role in modulating fibroblast function
Correspondence
Adam C. Midgley, Institute of Nephrology, Wales Kidney Research Unit, Division of
Infection and Immunity, Cardiff University, College of Biomedical and Life Sciences,
University Hospital of Wales, Heath Park, Wales CF14 4XN, UK. Tel.: (02920)
748446; fax: (02920) 748470;
e-mail: midgleyac@cardiff.ac.uk
Accepted for publication 10 February 2016
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
531
Aging Cell (2016) 15, pp531–541 Doi: 10.1111/acel.12462
Ag
in
g 
Ce
ll
(Luckett & Gallucci, 2007). One later study demonstrated that IL6Ra-ERK
signaling improved wound healing (McFarland-Mancini et al., 2010). In
contrast to IL6, IFN-c decreased formation of new granulation tissue in
rats and dysregulated collagen production and in vitro experiments
demonstrated that IFN-c decreased collagen synthesis in rat fibroblasts
(Laato et al., 2001). IFN-c-KO mice displayed accelerated collagen
deposition, granulation tissue formation and wound healing, subsequent
to increased TGF-b1 activity and decreased IFN-c/STAT1 activation (Ishida
et al., 2004). These studies highlight the differential roles of the immune
response in wound healing, whether these cytokines modulate fibroblast
function through EGFR changes, has yet to be investigated.
Previous research has shown that treatment with the anti-inflamma-
tory and estrogen-derived 17b-estradiol (E2) attenuated the age-related
increase in inflammatory mediators (Girasole et al., 1992; Ray et al.,
1997). Estrogen-treated splenocytes had reduced levels of IFNc produc-
tion and modulated STAT1 binding activity, in inflammatory models (Dai
et al., 2009). A link between E2 and aging has already been established:
Differences in gene expression between young and aged wound biopsies
were found to be largely estrogen-regulated (Hardman & Ashcroft,
2008). Furthermore, E2 accelerated wound healing in ovariectomized
mice (Hardman et al., 2008). E2 has also been shown to have a role in
the regulation of EGFR and accelerated wound healing (Stabile et al.,
2005; Tsonis et al., 2013). E2 enters cells freely and interacts with
cytoplasmic target cell receptors, estrogen receptor-a (ERa) and estrogen
receptor-b (ERb). The ER-complex can enter the nucleus of the target cell
(Levin, 2005) and regulate gene transcription through the modulation of
co-transcription factors or by direct binding of DNA. Changes in ER and
EGFR expression followed similar profiles under E2 treatments and in
inhibition studies, suggesting co-regulation (Koibuchi et al., 2000).
Furthermore, the combined inhibition of ER and EGFR caused antipro-
liferative effects in cancer cells (Stabile et al., 2005). However, in MCF-7
breast cancer cells, E2 treatments were detrimental to EGFR expression
in an ERa- and miR-7-dependent manner (Masuda et al., 2012).
In this study, we investigated miR-7 transcription through the analysis
of its promoter region and identification of potential transcription
factors. We report a role for IFNc and STAT1 activation in the
upregulation of miR-7 transcriptional activity and expression in fibrob-
lasts. We also investigated the effect of E2 on gene expression and
function in young and aged fibroblasts, involving changes to STAT1
activation and modulation of its binding capacity. Finally, we examined
whether combinational treatments of TGF-b1 with E2 could restore the
differentiation potential in aged fibroblasts.
Results
Previously, we have shown in vitro that fibroblasts with high population
doubling levels (PDL) had low EGFR expression due to an age-associated
increase in miR-7 expression (Midgley et al., 2014). In this study, we
have investigated the relationship between EGFR and miR-7 further. At a
threshold of approximately PDL >24, EGFR expression declined and miR-
7 expression began to increase. Beyond PDL 27-29 (aged), mRNA
expression levels of EGFR and miR-7 were significantly different to PDL
17 (young) fibroblasts (Fig. 1A). Analysis of phosphorylation (p-) states of
EGFR and ERK1/2 by TGF-b1 demonstrated a loss of signaling capacity in
aged fibroblasts (Fig. 1B). The downregulation of EGFR by miR-7
impacted on the signaling kinase, ERK1/2, which is involved in an array
of functional pathways essential in wound healing: proliferation,
migration and differentiation.
Binding of miR-7 to highly conserved EGFR-30 UTR (Midgley et al.,
2014) results in the degradation of EGFR Mrna, and therefore,
translation to protein no longer transpires. Previous reports indicated
that the miR-7 promoter extends to 600 bp upstream of the pre-miR-7
coding region (Chou et al., 2010). In silico analysis of the putative
transcription start site (TSS) for pri-miR-7 determined its location to be
approximately 250 bp upstream of the miR-7 coding region, as
indicated by the density of highly conserved cap analysis gene expression
(CAGE) tags and TSS tags flanked by histone-3 lysine-4 trimethylation
(H3K4me3) sites (Fig. 2A). Therefore, a sequence 624 bp to 200 bp
upstream of the coding region (Fig. 2B) was analyzed in silico for
putative transcription factor-binding sites (Fig. 2C). Multiple STAT
(A)
(B)
Fig. 1 Increasing fibroblast population doubling level (PDL) correlates with
elevated miR-7 expression and decreased epidermal growth factor receptor (EGFR)
expression. (A) qPCR for miR-7 (red circles) and EGFR (green squares) mRNA
expression (**P = <0.01 when compared to PDL 17 (young) cultures). (B) Western
blots to assess p-EGFR (open bars) and p-ERK1/2 (black bars). GAPDH was used as
a loading control and data are normalized to young, untreated fibroblasts. Images
are representative of three blots, and all data are displayed as means  SEM of
three independent experiments. **P = <0.01.
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binding sites were found, including sites for STAT1, IFN-stimulated
regulatory element (ISRE) and IFN-stimulated transcription factor 3-c
(ISGF3G). These were situated upstream of a likely TSS location as
indicated by RNA Pol. III PSE, a strong determinant for the recruitment of
RNA polymerase III (Schramm & Hernandez, 2002). These potential
transcription factor-binding sites strongly suggested that STAT activation
could contribute to the upregulated expression of miR-7.
We investigated whether the mRNA expression of IFNc and IL6 and
downstream signaling proteins altered with cellular age, as was
previously suggested (Ershler & Keller, 2000; Busse et al., 2007). IFNc,
IL6, STAT1 and STAT3 mRNA were all significantly expressed at higher
levels in aged fibroblasts (Fig. 3A). Western blots were used to assess
activation levels of STAT1 and STAT3 (Fig. 3B). STAT1 exhibited strong
phosphorylation in aged fibroblasts; however, there was no significant
difference observed in p-STAT3 levels between aged and young
fibroblasts. Interestingly, there was a significant increase in the total
STAT1 protein present in aged cells. These observations were likely due
to increased IFNc production potentiating STAT1 and p-STAT1 levels.
Despite the increase in IL6 mRNA expression, activation of STAT3 did not
increase, suggesting the miR-7 changes may be dependent on the
phosphorylation of STAT1 rather than STAT3.
To investigate the role of the JAK/STAT1 pathway in miR-7
transcription, JAK activation was inhibited using JAK inhibitor 1 (JAKi1)
and Western blot was used to determine p-STAT1 as an outcome
(Fig. 3C). IFNc strongly phosphorylated STAT1 and increased total STAT1
protein expression by 4-fold. Treatment with JAKi1 prevented these
increases. The expression of miR-7 and EGFR in human lung fibroblasts
(hLF) (Fig. 3D) and human dermal fibroblasts (hDF) (Fig. 3E) was then
examined by qPCR. In both types of fibroblast, IFNc upregulated miR-7
expression significantly. EGFR mRNA expression was downregulated by
50%. JAKi1 significantly inhibited the IFNc induction of miR-7 and
completely prevented the reduction of EGFR expression.
In silico analysis was used to identify a potential suppressor of miR-7
transcription. The presence of an ER-activated estrogen response
element (ERE) was identified within 10 bp of the RNA Pol. III PSE and
overlapped the ISRE and ISGF3G binding sites (Fig. 4A). To determine
whether this ERE site was responsible for the regulation of miR-7
transcription, E2 – a prominent activator of ER – was used to stimulate
fibroblasts. Chromatin immunoprecipitation (ChIP) was used to investi-
gate ER association with the miR-7 promoter (Fig. 4B). Both ERa and ERb
had an increased association with the miR-7 promoter, under E2
stimulation. The effects of ER binding to the miR-7 promoter region were
assessed by qPCR for miR-7 and EGFR expression in hLF (Fig. 4C) and
hDF (Fig. 4D). Treatment with E2 resulted in an attenuation of miR-7 and
increased EGFR mRNA expression in both young and aged fibroblasts.
These results suggested that ER binding to ERE within the miR-7
promoter had a repressive role in miR-7 transcriptional regulation,
affecting the intracellular miR-7 levels, leading to reciprocal increases in
EGFR mRNA expression.
The anti-inflammatory effects of E2, including actions on IFN-c, have
been extensively investigated (Ray et al., 1997; Dai et al., 2009; Akabori
et al., 2010). To assess differential effects of E2 and IFNc on miR-7
promoter activation and the STAT pathway, fibroblasts were transfected
with empty pGL3b or miR-7-pGL3b. There was a significant, 7-fold
induction of luciferase activity stimulated by IFNc, compared to vector
controls (Fig. 5A). E2 treatment generated a significant 40% reduction
in luciferase activity. In cells that were treated with E2 + IFNc, the IFNc
luciferase response was inhibited by 60%. E2 also significantly antag-
onized IFNc induction of miR-7 and EGFR mRNA expression in hLF
(Fig. 5B) and hDF (Fig. 5C). EGFR mRNA following these treatments was
(A)
(B)
(C)
Fig. 2 Analysis of the miR-7 promoter
reveals STAT binding sites. In silico analysis
was used to determine (A) the putative
transcription start site (TSS) for miR-7-1
(blue box indicates region of predicted TSS,
as indicated by flanking CAGE tags and
H3K4me3 regions). Image was generated
and analyzed using miRStart (Institute of
Bioinformatics and Systems, National Chiao
Tung University, Hsinchu, Taiwan). (B)
Diagram of miR-7-1 coding region and
promoter region used for analysis (dashed
blue box). (C) The promoter region for miR-
7-1 was analyzed for recognized
transcription factor-binding sites using
MatInspector (Genomatix Software).
Transcription factors of interest are labeled,
and underlined sections indicate the
primers used for promoter amplification in
subsequent experiments.
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inversely correlated to miR-7 expression, as expected: IFNc significantly
reduced EGFR expression by approximately 50%, and the combination
of E2 + IFN-c resulted in an attenuation of the IFNc downregulation.
Western blot analysis (Fig. 5D) indicated that E2 + IFNc attenuated total
STAT1 and p-STAT1 protein, suggesting an additional role for E2 in
inhibiting STAT1 expression. Further analysis using electromobility shift/
supershift assay (EMSA) determined whether E2 treatment affected
STAT1 association with the miR-7 promoter, through competitive ER
binding (Fig. 5E). DNA shifts indicated that there was no constitutive
binding of nuclear protein to the probe (lanes 2 and 6). In contrast,
protein–probe interactions increased (shift) in aged fibroblasts (lanes 4
and 8). Supershifts were present when either anti-STAT1 (strong
supershift; lane 4) or anti-STAT3 (weak supershift; lane 8) was added
to the reactions. E2 treatment resulted in an observable shift (lanes 3, 5,
7 and 9); however, there was a noticeable reduction in the STAT1
supershift seen in aged fibroblasts (lane 5). These supershift assays
demonstrated that STAT1 had strong association with the putative
promoter region of miR-7, whereas STAT3 was weakly associated under
aged and E2 conditions. These results suggested E2-induced ER may
directly reduce the binding capacity of STAT1 to the same promoter
region.
In light of the findings that E2 treatment was able to suppress miR-7
expression, we sought to investigate the potential of E2 stimulation to
influence aged fibroblast capacity to respond to TGF-b1. Firstly, p-EGFR
and p-ERK1/2 levels in young and aged fibroblasts were analyzed by
Western blot (Fig. 6A). In young fibroblasts, TGF-b1 treatment resulted
in a significant upregulation of p-EGFR and p-ERK1/2. In aged fibroblasts,
TGF-b1 was able to significantly increase p-EGFR and p-ERK1/2 only
when in the presence of E2. These results indicated that E2 treatment
restored p-EGFR levels to a sufficient threshold to allow for the
phosphorylation of ERK1/2. Restoration of EGFR-ERK1/2 suggested E2-
treated aged fibroblasts would be able to respond to TGF-b1-driven
differentiation. Therefore, qPCR analysis measured the mRNA expression
of differentiation markers: aSMA (Fig. 6B), EDA-FN (Fig. 6C), and HAS2
(Fig. 6D). In young fibroblasts, the expression of the three markers
increased with TGF-b1 stimulation. In aged fibroblasts, significantly
increased mRNA expression levels were observed for all three markers
under combined treatment with TGF-b1 and E2. To confirm myofibrob-
(A)
(B)
(C)
(D) (E)
Fig. 3 Inflammatory regulators are
increased in aging fibroblasts and miR-7
induction is downstream of JAK/STAT1. (A)
qPCR analysis of interferon-c (IFNc), IL-6,
STAT1 and STAT3 mRNA expression. (B)
Western blots to assess total and p-STAT1/
STAT3. GAPDH was used to ensure equal
loading. (C–E.) Cells were pretreated with
10 lM JAK inhibitor 1 (JAKi1) for 1 h prior
to 72 h of incubation in serum-free (SF)
media, alone or containing 10 ng mL1
IFNc. (C) Western blot analysis of p-STAT1
(open bars) and total STAT1 (black bars).
GAPDH ensured equal gel loading.
Expression of miR-7 and epidermal growth
factor receptor (EGFR) mRNA in (D) hLF and
(E) hDF was analyzed by qPCR. Blots are
representative of three individual gels, and
all results are displayed as mean  SEM of
three separate experiments. **P = <0.01
and *P = <0.05.
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last differentiation, immunocytochemistry was used to stain for aSMA
stress fibers and F-actin rearrangement (Fig. 6E). In young fibroblasts,
TGF-b1 treatment resulted in the formation of aSMA stress fibers and F-
actin bundles throughout the cell cytoplasm. When E2 was used with
TGF-b1 to stimulate aged fibroblasts, aSMA stress fibers and F-actin
were detectable, unlike in the other treatment conditions. These results
suggested that E2-treated aged fibroblasts could undergo TGF-b1-driven
differentiation to phenotypes indicative of myofibroblasts.
To confirm that the changes in marker expression were correlated
with restoration of EGFR-associated function, we sought to assess
proliferation (Table 1; Fig. S1A–B, Supporting information), migration
(Table 1; Fig. S1C–D, Supporting information), and contraction (Table 2;
Fig. S2A–B, Supporting information). E2 stimulation had no significant
effect on the rate at which young fibroblasts proliferated or migrated
(Table 1); however, in aged fibroblasts, proliferation was increased with
E2 treatments vs. untreated control and E2 significantly increased
migration rates to those comparable with young cells. Young fibroblasts,
seeded onto collagen gels, contracted the gels significantly when
exposed to TGF-b1 (approximately 40% by day 6) (Table 2). Aged
fibroblasts also contracted the gels in response to TGF-b1 by day 6, but
to a lesser extent (approximately 14% by day 6). Combinational
treatment with E2 and TGF-b1 restored contraction in aged fibroblasts,
comparable to that seen in TGF-b1-stimulated young fibroblasts
(approximately 35% by day 6). These data suggest E2 treatment was
beneficial in the restoration of EGFR-associated functionality in aged
fibroblast cells to rates observable in young fibroblasts, in addition to
rescuing reductions in TGF-b1-driven contraction. Furthermore, we also
used IFN-c treatments to demonstrate attenuation of fibroblast func-
tionality, as expected. E2, however, was able to effectively counter-act
the inhibitory effect of IFN-c across all three functional assays.
Discussion
Chronic nonhealing wounds are a prominent problem within health care
for the elderly and diabetics. While many factors contribute to the
persistence of chronic wounds, nonresponsive or senescent-like fibrob-
lasts at the wound edge play a major role. Our previous research
implicated the loss of EGFR as a primary cause for age-associated
resistance to differentiation, which was rescued when miR-7 was
inhibited (Midgley et al., 2014). Indeed, dysregulated miR-7 expression
in the skin and sera of patients has been linked to the progression of
scleroderma (Etoh et al., 2013) and dermatomyositis (Oshikawa et al.,
2012), providing evidence for the importance of miR-7 expression and
function regarding cutaneous disorders. Here, we report that E2
treatment attenuated miR-7 expression, positively regulated EGFR mRNA
expression, and restored functionality to aging fibroblasts. This was
supported by E2-dependent reductions in miR-7 transcriptional activity,
which involved attenuation of the binding activity, expression, and
phosphorylation of the potent miR-7 activator, STAT1. This research
suggests that an E2 treatment regime could be of therapeutic benefit in
nonhealing wounds.
An ERE site and several STAT1 and STAT binding sites were identified
on the miR-7 putative TSS. ER binds to ERE with high affinity, in response
to E2 (Klinge et al., 2001). As the ERE site overlapped with the ISRE and
ISGF3G binding sites, it was hypothesized that E2 may potentiate or
suppress STAT-complex binding. The data reported here suggested the
latter that a suppression of miR-7 transcriptional activity was the active
mechanism. In contrast, the activation of STAT1 by IFNc stimulation
resulted in potentiation of miR-7 transcriptional activity; here, we
suggest that this was through ISRE, ISGF3G, and upstream STAT1
binding sites. Levels of STAT3 bound to the miR-7 promoter probe,
observed in E2-treated young fibroblasts, may be causative of increased
EGFR expression and activity, as recent research has identified an
increase in STAT3 signaling in the presence of EGFR/IL6R association and
co-activation (Wang et al., 2013). STAT1 forms complexes with STAT2
and IRF9 to activate ISGF3G/ISRE (Darnell et al., 1994); however, STAT3
suppressed STAT1-dependent gene activation and inhibited STAT1
heterodimer formation (Ho & Ivashkiv, 2006). Furthermore, in tumor
cell lines, STAT3 promoted proliferation and cell survival, while STAT1
was antiproliferative and pro-apoptotic (Pensa et al., 2009). The low
(A)
(B)
(C)
(D)
Fig. 4 Estrogen receptors bind to the miR-7 promoter and suppress miR-7
expression. (A) Immediate nucleotide sequence upstream of the RNA polymerase III
proximal sequence element (RNA Pol. III PSE); ER-activated estrogen response
element (ERE) is indicated in bold. (B) Young fibroblasts were incubated with
serum-free (SF) medium alone (open bars) or 107 M E2 (gray bars) for 24 h.
Following treatments, ERa/ERb association with miR-7 promoter was assessed by
ChIP (IgG = negative control ChIP; Input = starting sonicated DNA). Cells were
incubated in SF medium alone (white bars) or SF medium containing 107 M E2
(black bars) for 72 h and expression of miR-7 and epidermal growth factor
receptor (EGFR) mRNA in (C) hLF and (D) hDF was analyzed by qPCR. Results are
shown as mean  SEM of three individual experiments. *P = <0.05, **P = <0.01.
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levels of STAT3 bound to the miR-7 promoter, in this study, may
therefore have an alternative role to transcriptional transactivation of
miR-7; a mechanism for which should be elucidated in future research.
Also of interest would be defining the active ER involved, as both ERa
and ERb were identified to associate with the miR-7 promoter; however,
each was reported to have different roles in cell function and wound
healing (Gilliver et al., 2010).
Chronic inflammation or persistence of bacterial infection is prob-
lematic in chronic wounds. In addition, telomerase-independent senes-
cence and fibroblast dysfunction are regarded as being central to failure
of wound closure (Wall et al., 2008). The persistence of inflammation
and over-activation of immune-regulated pathways, such as IFN-
stimulated responses, may contribute to the senescence-like state of
chronic wound fibroblasts, through induction of miR-7. Increased levels
of miR-7 activity, promoted through stimulation by IFNc from immune
cells such as natural killer T-cells, macrophages, dendritic cells
(Koutoulaki et al., 2010; Robinson et al., 2010; Nakano et al., 2012)
or from aging fibroblasts themselves, could be the active mechanism in
explaining telomerase-independent senescence of cells. However, the
effects of E2 on IFNc production may alter between cell types, as shown
in adherent and nonadherent splenocytes (Nakaya et al., 2006). Taken
together, the findings here showed that regulation of IFNc and IL6
expression by E2 suggests a broader role for E2 in modulating the
immune response. Indeed, E2 regulation of macrophage activity has
been previously shown (Emmerson et al., 2009). Induction or inhibition
of immune regulation of fibroblasts could potentially be used as
antifibrotic or pro-healing treatments, respectively.
E2 treatment restored aged fibroblasts to a ‘young state’ in
preparation for TGF-b1-driven differentiation, through downregulation
of miR-7 and upregulation of EGFR. Fibroblast functionality was almost
completely restored, both proliferation and migration benefited from E2.
In addition, contraction was also rescued; this could also be explained
through miR-7 targeting the Akt/FAK pathway (Fang et al., 2012).
However, in aging fibroblasts, the expression of EGFR is lost, suggesting
the activity of EGFR-dependent Akt/FAK would also be diminished. In
silico evidence suggests that EGFR, Akt, PI3K and c-Myc are miR-7
targets; all involved in the EGFR signaling axis (as found in TargetScan
and GoDAVID databases). Therefore, miR-7 could be considered a
regulator of fibroblast signaling pathways during wound healing. The
JAK/STAT1 pathway provides a novel explanation for the upregulation of
miR-7 observed in aged fibroblast cultures. In conclusion, we propose a
mechanism wherein E2 activation of ER results in inhibited STAT1
expression and activity and attenuated binding of STAT1 to the miR-7
promoter, thereby regulating transcriptional activity and expression of
miR-7. This research implicates E2 as a potential treatment option, in
producing beneficial outcomes in the context of fibroblast-mediated
healing, especially in chronic wound conditions.
Experimental procedures
Materials and reagents
All reagents were from Sigma-Aldrich (Poole, UK) unless otherwise
stated. Primary antibodies and dilutions for Western blot and immuno-
cytochemistry were polyclonal rabbit anti-p-EGFR (1:1000), anti-p-ERK1/
2, anti-p-STAT1, anti-p- STAT3, anti-STAT1, and anti-STAT3 (all at
1:2000) from Cell Signalling Technology Inc. (Beverly, MA, USA),
polyclonal mouse anti-GAPDH (1:5000) from Abcam (Cambridge, UK),
(A) (B)
(D) (E)
(C)
Fig. 5 Transcriptional activity of miR-7 is strongly induced by interferon-c (IFNc)/STAT1 and attenuated by E2. (A) Fibroblasts were transfected with empty pGL3b vector
(white bars) or pGL3b-miR-7 (black bars). Cells were incubated in serum-free (SF) media alone, or SF media containing either 107 M E2, 10 ng mL1 IFNc or 107 M E2 with
10 ng mL1 IFNc for 24 h. Firefly luciferase was measured using a luminescence plate reader. Renilla luciferase was co-transfected for efficiency and normalization. qPCR
was used to assess miR-7 and epidermal growth factor receptor (EGFR) mRNA in (B) hLF and (C) hDF. (D) Western blots for total and p-STAT1. GAPDH ensured equal protein
loading. E. Electromobility shift/supershift assay (EMSA) using biotinylated miR-7 promoter DNA investigated binding potential of proteins. Supershift assay used STAT1 and
STAT3 antibodies to identify specific protein–promoter interactions. Images shown are representative of three individual gels. All results are displayed as mean  SEM of
three individual experiments. Immunoblots are representative of three experiments. *P = <0.05, **P = <0.01.
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and anti-aSMA (1:50) from DAKO (Aachen, Germany). All RT–QPCR
reagents were obtained from Life Technologies (Paisley, UK). Other
reagents used were E2 (Sigma-Aldrich) and recombinant human IFNc
and TGF-b1 (R&D Systems, Abingdon, UK).
Cell culture
Primary hLF (AG02262; NIA Aging Cell Respiratory, Corriel Institute,
Camden, NJ, USA) and hDF (GM23967; NIA Aging Cell Respiratory) were
cultured in 10% fetal calf serum (FCS) and Dulbecco’s modified Eagle’s
medium (DMEM)/F-12 Ham’s medium as previously described (Midgley
et al., 2014). All cells were growth arrested in serum-free (SF) medium
for 48 h before use in experiments, unless otherwise stated. Young
fibroblasts were cells at passages 6–8 [population doubling level (PDL)
15–20], while aged fibroblasts were cells at presenescent late passages
14–15 (PDL 26–28); cells underwent senescence at PDL 30 as
determined by growth curves (data not shown). All experiments were
performed on confluent cell monolayers except for those experiments
using antibody visualization (optimal confluence was approximately
70%). Cells were differentiated to myofibroblasts by incubating fibrob-
last cultures in SF medium containing 10 ng mL1 TGF-b1 for 72 h.
Real time and reverse transcription–quantitative polymerase
chain reaction
Isolation of RNA and cDNA reverse transcription was as previously
described (Midgley et al., 2014). Reverse transcription–quantitative
polymerase chain reaction (RT–qPCR) was performed according to the
(A)
(B)
(E)
(C) (D)
Fig. 6 E2 rescues the transforming growth factor (TGF)-b1 differentiation response in aging fibroblasts. (A) Western blot was used to assess p-EGFR (open bars) and p-ERK1/
2 (black bars) in fibroblasts treated with TGF-b1 and/or E2 for 24 h. GAPDH was used as a loading control, and data were normalized to young, untreated fibroblasts. Images
are representative of three blots (*P = <0.05/**P = <0.01 – significance against young, untreated; #P = <0.05/##P = <0.01 – significance against aged, untreated). Cells
were incubated with SF medium (white bars), 107 M E2 (black bars), 10 ng mL1 TGF-b1 (light gray bars) or 107 M E2 and 10 ng mL1 TGF-b1 (dark gray bars) for 72 h.
qPCR was used to assess mRNA expression of (B) aSMA, (C) EDA-FN, and (D) HAS2. Results are shown as mean  SEM of three individual experiments. *P = <0.05,
**P = <0.01. (E) Cells were stained for a-smooth muscle actin (aSMA) (top row, each panel) or F-actin (bottom row, each panel) and visualized using fluorescence
microscopy. Images are representative of five individual experiments. White scale bars represent 50 lm.
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TaqMan or Power SYBR Green Master Mix kit protocols and using the
ViiA7 Fast Real-Time PCR System (Life Technologies). Ribosomal RNA
(rRNA) was used as an endogenous control. MicroRNA-RT and qPCR
were performed for miR-7 according to TaqMan MicroRNA Assay Kits
(Life Technologies). EGFR, aSMA, HAS2 and STAT1 primers were
commercially available. Primers (50–30) for IFNc (forward: ACAGGG
AAGCGAAAAAGGAGT; reverse: TATTGCAGGCAGGACAACCAT), IL6
(forward: TGAACTCCTTCTCCACAAGCG; reverse: TGGAATCTTCTCCT
GGGGGTA), STAT3 (forward: ATCCTGGTGTCTCCACTGGT; reverse: GC
TACCTGGGTCAGCTTCAG) and EDA-FN (forward: ACAGTCAGTGTGTG
GTTGCCTT; reverse: TTCAGGTCAGTTGGTGCAGG) were custom
designed. All custom primer pairs were tested for efficiency by log10
standard dilutions, where ≥90% was deemed sufficient.
Western blot analysis
Total protein was extracted in RIPA lysis buffer containing 1% protease
inhibitor cocktail (PIC), 1% PMSF, and 1% sodium orthovanadate (Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Protein was quantified
before SDS-PAGE and transfer to nitrocellulose. Membranes were
blocked with 5% BSA/0.5% Tween-20/PBS for 1 h, RT, followed by
incubation with primary antibodies diluted in 1% BSA/0.1% Tween-20/
PBS, overnight at 4 °C. Following wash steps, membranes were
incubated in secondary anti-rabbit/mouse IgG HRP conjugate (Cell
Signalling Technology; 1:5000 dilution, 1% BSA/0.1% Tween-20/PBS).
Detection was performed using ECL reagent (GE Healthcare, Bucking-
hamshire, UK) and exposure to X-ray film (GE Healthcare).
Chromatin immunoprecipitation
Protein-DNA was cross-linked in 0.75% v/v formaldehyde (10 min, RT)
followed by 125 mM w/v glycine (5 min, RT). Cells were harvested into
1 mL ice-cold PBS and pelleted at 1000 g for 5 min before resuspension
in FA lysis buffer (50 mM HEPES pH7.5, 140 mM NaCl, 1 mM EDTA pH 8,
1% Triton-X100, 0.1% sodium deoxycholate, 0.1% SDS, 1% PIC and
1% PMSF). Lysates were sonicated to shear DNA to approximate
fragments of 1000 bp and centrifuged for 30 s, 8000 g at 4 °C.
Supernatant was transferred to new Eppendorfs, and 50 lL was
removed for use as an input sample. A known volume of 25 lg of
protein in RIPA buffer was immunoprecipitated (IP) using anti-ERa or
anti-ERb antibody-linked protein A/G beads (pre-absorbed with soni-
cated single-stranded herring sperm DNA). IP was completed with an
overnight rotating incubation at 4 °C. The bead complexes were
centrifuged for 1 min at 2000 g, and the supernatant was removed.
Beads were washed with wash buffer (0.1% SDS, 1% Triton-X100,
2 mM EDTA pH8, 150 mM NaCl, 20 mM Trizma base pH8) three times
and once with final wash buffer (wash buffer containing 500 mM NaCl).
Protein–DNA was eluted with elution buffer (1% SDS, 100 mM NaHCO3)
at RT for 1 h with continuous rotation. Supernatant was protein digested
with 50 lg/mL proteinase K at 65 °C for 5 h. DNA was extracted with
phenol–chloroform and precipitated in ethanol–glycogen, before resus-
pension in nuclease-free H2O. DNA amplified from the ChIP elute was
visualized on EtdBr–agarose gel.
Luciferase reporter plasmid generation
A 424-bp miR-7 promoter insert was PCR amplified using Phusion DNA
polymerase (New England Biolabs, Herts, UK). Primers (50–30): forward
CTTGACAGGTTTAGGGAGCGT and reverse AGGTCCCCAAAAGGTT
GAGAC (with KpnI and XhoI endonuclease restriction sites, respectively).
Inserts were ligated into KpnI- and XhoI-digested pGL3Basic (pGL3b)
Vector using T4 DNA ligase (New England Biolabs) overnight at 16 °C.
The pGL3b Vector containing the promoter insert (pGL3b-miR-7) was
heat-shock-transformed into one-shot competent Escherichia coli (New
Table 1 Proliferation and migration assays in young and aged fibroblasts
Culture conditions
Proliferation (at day 3) Migration (at day 3)
Mean AlamarBlue
fluorescence
(9103 arbitrary units)  SEM
Significant? (vs. control)
(*P ≤ 0.05, **P ≤ 0.01)
Mean % wound closure
(of original wound size)  SEM
Significant? (vs. control)
(*P ≤ 0.05, **P ≤ 0.01)
Young Control 27.56  3.15 – 99.66  0.13 –
E2 31.85  2.10 N/S 99.36  0.40 N/S
IFNc 19.33  2.13 * 85.92  4.18 *
E2 + IFNc 25.35  1.85 N/S 98.40  0.63 N/S
Aged Control 18.04  1.39 – 56.12  1.09 –
E2 31.65  1.73 ** 87.77  3.28 **
IFNc 9.32  0.88 ** 32.40  4.85 **
E2 + IFNc 24.31  1.90 * 77.26  5.09 **
Table 2 Collagen gel contraction assays in young and aged fibroblasts
Culture conditions
Contraction (at day 6)
Mean % contraction
(of original collagen
gel size)  SEM
Significant? (vs. day 1)
(*P ≤ 0.05, **P ≤ 0.01)
Young Control 23.72  3.09 *
E2 22.37  2.35 **
TGFb1 38.55  2.70 **
IFNc 13.47  0.69 N/S
E2 + TGFb1 33.35  3.60 *
E2 + IFNc 11.10  1.09 N/S
TGFb1 + IFNc 16.08  1.76 *
Aged Control 6.78  2.30 N/S
E2 6.08  0.75 *
TGFb1 13.79  1.23 *
IFNc 7.03  1.06 N/S
E2 + TGFb1 33.48  2.77 **
E2 + IFNc 8.18  2.26 N/S
TGFb1 + IFNc 6.38  1.89 N/S
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England Biolabs) and grown on ampicillin–agar. Plasmid DNA was
purified from colonies according to the Miniprep Kit protocol (Sigma-
Aldrich). Cloned pGL3b-miR-7 was confirmed with DNA sequencing
(DNA Sequencing Core, Cardiff University, Cardiff, UK).
Transfection and luciferase reporter analysis
Plasmid pGL3b-miR-7 transfections were completed using Lipofectamine
LTX (Life Technologies) following optimization. Reporter analysis was
performed 72 h post-transfection using the Dual-Luciferase reporter
assay kit (Promega, Southampton, UK) and detected with a FLUOstar
OPTIMA plate reader (BMG Labtech, Ortenberg, Germany). Renilla
luciferase was co-transfected with pGL3b-miR-7 and used as a control
for transfection efficiency and normalization.
Electromobility shift/supershift assay
A 424-bp miR-7 promoter fragment was PCR amplified from genomic
DNA using Phusion DNA polymerase (New England Biolabs), biotinylated
forward primer; 50-CTTGACAGGTTTAGGGAGCGT-30 and reverse pri-
mer; 50-AGGTCCCCAAAAGGTTGAGAC-30. Nuclear extraction was per-
formed according to the following protocol: Total cell lysate was
resuspended in hypotonic buffer (20 mM Tris-HCl pH7.4, 10 mM NaCl,
3 mM MgCl2) on ice for 15 min. About 10% NP40 detergent was added
and samples vortexed. Homogenate was centrifuged for 10 min at 1000
g at 4 °C, and the supernatant (cytoplasmic fraction) was removed and
frozen for future use. The pellet was resuspended in cell extraction buffer
(100 mM Tris-HCl pH7.4, 2 mM Na3VO4, 100 mM NaCl, 1% Triton X-100,
1 mM EDTA, 0.1% SDS, 1 mM NaF, 0.5% deoxycholate, 20 mM Na4P2O7,
1% PIC) and incubated on ice for 30 min with regular mixing. Samples
were centrifuged at 14 000 g at 4 °C for 30 min, and the supernatant
(nuclear extract) was transferred to fresh Eppendorfs. Protein was
quantified and EMSA performed according to the following protocol: a
10 lL binding reaction was set up, containing 100 ng protein,
50 fmol lL1 biotinylated-DNA probe, 1 lg lL1 poly dI:dC, 50 lg lL1
BSA, 0.1 M DTT, 0.1 M MgCl2, buffer D (20 mM HEPES-KOH pH7.9, 20%
glycerol, 0.2 mM EDTA, 0.1 M KCl, 0.5 mM PMSF, 1 mM DTT), and H2O.
The reaction was incubated at 30 °C for 1 h before the samples were run
on a 4.5% nondenaturing acrylamide gel at 150 V in ice-cold 0.59 TBE
buffer. The DNA was transferred in 0.59 TBE at 30 mA for 1 h, onto
nylon membranes, UV-cross-linked and blocked with 5% milk. Strepta-
vidin–HRP was incubated with the membrane for 30 min (darkness, RT).
DNA bands were detected using ECL reagent (GE Healthcare, Amersham,
UK) and exposed to X-ray film (GE Healthcare). For supershift assays, 1 lg
of anti-STAT1 or anti-STAT3 antibody was added to the binding reaction.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 10 min at room temper-
ature. To ensure visualization of intracellular proteins, fixed cells were
permeabilized with 0.1% Triton X-100 in PBS (10 min, RT). Slides were
washed with PBS and then blocked in 1% BSA/PBS for 30 min prior to a
wash step with 0.1% BSA/PBS. Subsequently, the slides were incubated
with mouse anti-aSMA antibody diluted in 0.1% BSA/PBS overnight at
4 °C. Following a further wash step, slides were incubated with
secondary anti-mouse IgG/AlexaFluor 488 (Invitrogen, Paisley, UK) in
0.1% BSA/PBS (1 h, RT in darkness). Cells were then mounted and
analyzed by fluorescence microscopy. Alternatively, slides were incu-
bated with phalloidin-FITC (Sigma-Aldrich; 2 h, RT in darkness), to
visualize F-actin.
Proliferation assay
Cells were seeded at approximately 5 9 104 per mL for 24 h before
growth arrest. AlamarBlue (Life Technologies) was added to media at
10% v/v at each 24-h time-point, and incubated for 1 h; aliquots of
conditioned AlamarBlue/medium were transferred to clear 96-well plates
and fluorescence was measured at excitation wavelength of 540 nm and
emission at 590 nm on a FLUOstar OPTIMA plate reader (BMG Labtech).
Measurements were made over a course of 72 h of cellular treatments
and are expressed as arbitrary fluorescence units.
Migration/scratch-wound healing assay
Scratching quiescent cell monolayers with sterile 200 lL pipette tips
generated linear denuded areas. The cells were gently washedwith PBS to
remove detached cells and then replenished with fresh SF medium
containing appropriate cytokine treatments. The wound size was
photographed every 24 h, up to 72 h or until closure, using an Axiovert
100 M inverted microscope fitted with a digital camera (ORCA-1394;
Hamamatsu Photonics, K.K., Hamamatsu, Japan). Measurements were
obtained using IMAGEJ (NIH Software, Bethesda, MD, USA). Data are
expressed as% reduction inwound area, compared towound area at 0 h.
Collagen gel contraction assay
Type I collagen was extracted from rat-tail tendon as previously
described (Cawston & Barrett, 1979). Approximately 2.5 9 105 per mL
fibroblasts were seeded onto preformed collagen lattices (2.5 mL 20%
FCS-DMEM, 500 lL 0.1 M NaOH and 1 mg mL1 type I collagen, total
volume of 5 mL). Fibroblast populated collagen lattices (FPCLs) were
maintained at 37 °C, in a 5% CO2 atmosphere for 1 h, for collagen
polymerization to occur. FPCLs were gently detached from the plate
edges and resuspended in SF medium containing appropriate cytokine
treatments. FPCLs were measured at days 1, 3 and 6 after initial lattice
fabrication. The average FPCL contraction values were obtained from
IMAGEJ (NIH Software) analysis and are expressed as % reduction in gel
diameter, compared to the gel diameters, at 0 days.
In silico analysis
Putative TSS and potential transcription factor-binding regions were
analyzed using miRStart (National Chiao-Tung University, Hsinchu,
Taiwan) and Genomatic MatInspector (Genomatix Software GmbH,
Munich, Germany).
Statistical analysis
Densitometrical analysis was by IMAGEJ (NIH Software). Graphical data are
displayed as means  SEM. One- or two-way ANOVAs and post-test
Bartlett’s were used to determine statistical differences across multiple
data groups. The unpaired two-tailed Student’s t-test was used to
identify statistical significance. Data were analyzed using the software
GraphPad Prism version 4.0a (GraphPad Software Inc., La Jolla, CA, USA)
and *P ≤ 0.05 and **P ≤ 0.01 were considered significant.
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Fig. S1 (A–B) Fibroblast cultures were assessed for proliferative capacity
under the indicated treatments over the course of 3 days, using the
AlamarBlue assay as described under methodology. (C–D) Migration ability
was determined by scratch-wound assay, and under indicated treatments.
Fig. S2 Fibroblast contraction was examined through collagen gel contrac-
tion assays.
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